⚠️ Safety Alert
MHRA
ACE-inhibitors: Be aware of the distinction between bradykinin- and histamine-mediated angioedema, as treatment strategies differ significantly
Angioedema associated with ACE-inhibitors can present with delayed onset, requiring heightened clinical awareness and vigilance beyond initial prescription periods Bradykinin-mediated angioedema (ACE-inhibitor…
16 Jun 2026
View brief →